Does bile acid turnover help dispose of cholesterol and keep LDL cholesterol lower?

Cholesterol homeostasis relies heavily on hepatic catabolism. The conversion of cholesterol into bile acids and its subsequent excretion represent the primary metabolic pathway for disposing of excess cholesterol.

Clearance and disposal pathways

• Excretion capacity: Approximately 30% to 50% of daily cholesterol elimination occurs via hepatic bile acid synthesis and fecal loss. In typical adults, 400 to 600 mg of cholesterol is converted into bile acids daily, representing nearly half of newly synthesized cholesterol.
• Enterohepatic conservation: While 95% of bile acids are actively reabsorbed in the terminal ileum, the 5% that escapes reabsorption (0.2 to 0.6 g daily) is excreted in stool. This continuous loss serves as a crucial "sink" that maintains steady-state hepatic demand for cholesterol.

Molecular mechanisms of elevation

• SREBP-2 suppression: Constraining bile acid turnover limits this conversion, causing intracellular cholesterol to accumulate in hepatocytes. This excess hepatic cholesterol suppresses sterol regulatory element-binding protein-2 (SREBP-2) activity.
• LDLR downregulation: Suppressed SREBP-2 activity directly downregulates hepatic LDL receptor (LDLR) expression, which is initiated by the rate-limiting enzyme cholesterol 7α-hydroxylase (CYP7A1).
• Circulating LDL accumulation: Reduced hepatic LDLR expression impairs the liver's ability to clear apoB-containing LDL particles, elevating circulating LDL cholesterol. This causal pathway is validated by the hypercholesterolemia seen in genetic CYP7A1 deficiencies and the corresponding LDL-lowering efficacy of bile acid sequestrants.

Bottom line

• Bile acid synthesis and fecal excretion eliminate up to half of the body's daily cholesterol; constraining this turnover triggers hepatic cholesterol buildup, downregulates LDL receptors via SREBP-2 suppression, and elevates circulating LDL cholesterol.